UK Market for IVDs Up 50% in 2 years
No-one can be surprised that the Covid-19 pandemic has had a dramatic effect on IVD revenues in the UK as in the rest of the world. As the BIVDA Market Audit (MA) shows for the 12 months to June 2021, revenues have increased by over 50%, and, of course, most of that increase is due directly to testing for Coronavirus. Within that raw number are many variations, however, with the lock-down causing a temporary near-suspension of routine testing, and a number of markers and specific investigations greatly increased as a result of the need to monitor and diagnose complications and to differentiate Covid-19 from other respiratory infections. The graph below shows the impact by speciality, although these numbers are not corrected for glucose self-testing or for the government contracts for Lateral Flow Tests (LFTs) that were awarded to non-BIVDA member companies
For the detail and analysis behind these, and for the only reliable source of UK market data for IVDs, ensure your company is a participant in the MA. If in doubt, or for more information, contact John Bagshaw who will be delighted to help.
